The Department of Health and Human Services will be conducting CHAMPS System maintenance this weekend. As a result, the system will not be available between 6:00 pm EST on November 16 through 9:00 am EST on November 17, 2024. Providers with questions should contact Provider Support at 1-800-292-2550 or ProviderSupport@Michigan.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Prescription Drug Affordability Board has posted the agenda for its November 26, 2024, meeting.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
MO HealthNet completed the annual review of all drug coverage criteria for the Prior Authorization Process.
For more information, contact NACDS’ Mary Staples at 817-442-1155.
The state legislature released the Final Report of the Committee to Study the Impact of Pharmacy Benefit Manager Operations on Cost, Administration and Distribution of Prescription Drugs. The report recommends PBM legislation for 2025 that addresses improvements to the state’s pricing and appeals processes laws.
For more information, please contact NACDS’ Mike Sargent at 207-272-6435.
The Department of Medicaid announced the selection of four managed care plans they will contract with for the “Next Generation of MyCare,” Medicaid’s dual eligible healthcare program. The new plan contracts will begin January 1, 2026.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Prescription Drug Affordability Board (PDAB) posted an agenda and meeting materials for its November 20, 2024, meeting. Please note the “Board discussion and approval of SB 192 upper payment limit final report to send to the Oregon Legislature”. You must register in advance to participate.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.
The Department of Health issued a buprenorphine guidance document, which focuses on reducing barriers to accessing Medications for Opioid Use Disorder (MOUD). The document includes a frequently asked questions section that addresses inquiries from prescribers and pharmacists about MOUD. It also offers insights on enforcement practices, buprenorphine prescribing, continuity of care and telehealth prescriptions. All questions can be directed to RA-DHRESOURCESERVICE@pa.gov.
For more information, contact NACDS’ Jill McCormack at 717-592-8977.
The Board of Pharmacy has approved the updated protocol for Administration of Vaccines by pharmacists. These updates reflect changes made through HB 3988 enacted during the legislative session, which includes the ability for pharmacy technicians to administer vaccines.
Also in South Carolina, the Board of Pharmacy is accepting nominations for Board Members from the Fifth and Seventh Congressional Districts. The fifth district is made up largely of Cherokee, York, Chester, Union, Fairfield, Lancaster, Kershaw, Lee and Sumter counties. The Seventh District is primarily made up of Chesterfield, Marlboro, Darlington, Florence, Marion, Dillon, Horry and Georgetown counties. For more information or to submit a nomination, email contact.pharmacy@llr.sc.gov. The Deadline to apply is November 30, 2024.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
In accordance with the Tennessee Department of Commerce and Insurance, Division of Insurance Rule 0780-01-95-.10(1)(b) and 0780-01-95-.10(2)(b), the deadline to submit an attestation of low-volume status and proof of actual prescription volume to your contracted PBMs is December 1, 2024. Volume status is based on your pharmacy’s actual prescription volume from July 1, 2023, to June 30, 2024.
For more information, contact NACDS’ Leigh Knotts at 803-243-7207.
